Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Recombinant DNA in Fermentation Products is of No Regulatory Relevance

Version 1 : Received: 16 May 2022 / Approved: 19 May 2022 / Online: 19 May 2022 (04:55:19 CEST)

How to cite: Lensch, A.; Duwenig, E.; Dederer, H.; Kärenlampi, S.; Custers, R.; Borg, A.; Wyss, M. Recombinant DNA in Fermentation Products is of No Regulatory Relevance. Preprints 2022, 2022050251. https://doi.org/10.20944/preprints202205.0251.v1 Lensch, A.; Duwenig, E.; Dederer, H.; Kärenlampi, S.; Custers, R.; Borg, A.; Wyss, M. Recombinant DNA in Fermentation Products is of No Regulatory Relevance. Preprints 2022, 2022050251. https://doi.org/10.20944/preprints202205.0251.v1

Abstract

A large variety of fermentation products are used in food and feed production, but also in other industries, and many of these products are produced with genetically modified microorganisms (GMMs). In food and feed production, prominent examples are amino acids, vitamins, food and feed enzymes, colorants, non-caloric sweeteners and human milk oligosaccharides. From a regulatory perspective, fermentation products are typically produced under containment. This means that premises, equipment and work processes need to be designed to prevent or at least minimize release of GMMs into the environment. The fermentation products themselves should not contain any live cells of the GMM. Over the past years, there have been concerning developments, particularly in the European Union, stipulating that also absence of recombinant DNA might be interpreted as a regulatory requirement for fermentation products produced with GMMs. In this paper, we (i) attempt to place these developments into the historical context, (ii) sketch the potential negative repercussions for the food and feed industries, (iii) elaborate on the safety of recombinant DNA, and (iv) postulate that recombinant DNA should remain an integral part of the safety assessment of fermentation products but should not be misconstrued as a criterion for regulatory classification of products of biotechnology.

Keywords

Recombinant DNA; scope of legislation; regulatory compliance; analytical capabilities; safety; global harmonization

Subject

Biology and Life Sciences, Biology and Biotechnology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.